ES540172A0 - Procedimiento para produccion del compuesto (-)-trans-4-(4-fluorofenil)-3-(4-metoxifenoxi)metilpiperidina. - Google Patents

Procedimiento para produccion del compuesto (-)-trans-4-(4-fluorofenil)-3-(4-metoxifenoxi)metilpiperidina.

Info

Publication number
ES540172A0
ES540172A0 ES540172A ES540172A ES540172A0 ES 540172 A0 ES540172 A0 ES 540172A0 ES 540172 A ES540172 A ES 540172A ES 540172 A ES540172 A ES 540172A ES 540172 A0 ES540172 A0 ES 540172A0
Authority
ES
Spain
Prior art keywords
methylpiperidine
trans
metoxifenoxi
fluorofenil
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES540172A
Other languages
English (en)
Spanish (es)
Other versions
ES8601131A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrosan ApS
Original Assignee
Ferrosan ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan ApS filed Critical Ferrosan ApS
Publication of ES540172A0 publication Critical patent/ES540172A0/es
Publication of ES8601131A1 publication Critical patent/ES8601131A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Liquid Crystal Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES540172A 1984-02-07 1985-02-06 Procedimiento para produccion del compuesto (-)-trans-4-(4-fluorofenil)-3-(4-metoxifenoxi)metilpiperidina. Expired ES8601131A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/577,844 US4585777A (en) 1984-02-07 1984-02-07 (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT

Publications (2)

Publication Number Publication Date
ES540172A0 true ES540172A0 (es) 1985-11-16
ES8601131A1 ES8601131A1 (es) 1985-11-16

Family

ID=24310381

Family Applications (1)

Application Number Title Priority Date Filing Date
ES540172A Expired ES8601131A1 (es) 1984-02-07 1985-02-06 Procedimiento para produccion del compuesto (-)-trans-4-(4-fluorofenil)-3-(4-metoxifenoxi)metilpiperidina.

Country Status (12)

Country Link
US (1) US4585777A (h)
EP (1) EP0152273B1 (h)
JP (1) JPS60181071A (h)
AT (1) ATE46146T1 (h)
CA (1) CA1246082A (h)
DE (1) DE3572807D1 (h)
DK (1) DK53285A (h)
ES (1) ES8601131A1 (h)
FI (1) FI850449A7 (h)
GR (1) GR850309B (h)
IE (1) IE850286L (h)
NO (1) NO850444L (h)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223334B1 (en) * 1985-08-10 1991-07-10 Beecham Group Plc Process for the preparation of aryl-piperidine carbinols
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process
GB9700690D0 (en) 1997-01-15 1997-03-05 Smithkline Beecham Plc Novel process
ATE279393T1 (de) 1997-05-29 2004-10-15 Smithkline Beecham Corp Neues verfahren
AU2002301956B2 (en) * 1997-06-10 2006-02-09 Synthon B.V. 4-phenylpiperidine compounds
EE03970B1 (et) * 1997-06-10 2003-02-17 Synthon B.V. 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
WO2001085688A1 (en) 2000-05-12 2001-11-15 Synthon B.V. TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS
AU2001270858A1 (en) * 2000-07-17 2002-01-30 Smithkline Beecham Plc Novel processes for the preparation of 4-phenylpiperidine derivatives
AU2001211337A1 (en) * 2000-10-06 2002-04-15 Smithkline Beecham Plc Process for the preparation of aryl-piperidine carbinols and intermediates thereof
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
NL1017421C2 (nl) 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
EP1406624A4 (en) 2001-06-13 2005-03-30 Teva Pharma METHOD FOR PRODUCING PAROXETIN, WHICH IS ESPECIALLY FREE OF ALKOXY POLLUTION
US20070142389A1 (en) * 2005-12-20 2007-06-21 Pfizer Inc. Piperidine derivatives
CN101855218A (zh) 2007-09-13 2010-10-06 康塞特医药品有限公司 氘化的儿茶酚和苯并[d][1,3]间二氧杂环戊烯及其衍生物的合成

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds

Also Published As

Publication number Publication date
EP0152273B1 (en) 1989-09-06
EP0152273A2 (en) 1985-08-21
CA1246082A (en) 1988-12-06
EP0152273A3 (en) 1986-12-30
NO850444L (no) 1985-08-08
GR850309B (h) 1985-06-05
FI850449L (fi) 1985-08-08
DK53285D0 (da) 1985-02-06
JPS6135176B2 (h) 1986-08-12
IE850286L (en) 1985-08-07
JPS60181071A (ja) 1985-09-14
FI850449A0 (fi) 1985-02-04
ES8601131A1 (es) 1985-11-16
DE3572807D1 (en) 1989-10-12
FI850449A7 (fi) 1985-08-08
DK53285A (da) 1985-08-08
US4585777A (en) 1986-04-29
ATE46146T1 (de) 1989-09-15

Similar Documents

Publication Publication Date Title
ES540172A0 (es) Procedimiento para produccion del compuesto (-)-trans-4-(4-fluorofenil)-3-(4-metoxifenoxi)metilpiperidina.
SE8602723D0 (sv) Thiazoles, their production and pharmaceutical compositions containing them
NO174239C (no) Fremgangsmåte for fremstilling av et oralt, farmasöytisk preparat
IT8548267A0 (it) Derivati di i,4-diidropiridina e suoi sali, procedimento per produrli e composizione farmaceutica cheli contiene
DE3483798D1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate.
SE7702041L (sv) Forfarande for framstellning av 2,3-substituerade, 5,6-kondenserade 4(2h)-aminoalkoxi-pyranoner med hypotensiv, anti-ischemi-och antihostverkan
FI864970A0 (fi) Nya kristallina salter av aryloxi-propanolaminer, foerfarande foer deras framstaellning och deras anvaendning.
IT1231127B (it) Procedimento per la produzione di impiallacciatura di radica artificiale mediante fogli di legno rigati.
NO853782L (no) Fremgangsm¨te for fremstilling av terapeutisk aktive furo- pyridinderivater.
NO853551L (no) Fremgangsmaate ved fremstilling av prolinderivater og lignende forbindelser med antihypertensiv aktivitet.
BG44203A3 (en) Method for preparing of 2- oxyindol- 1- carboxamides
ES2046528T3 (es) Derivados heterotetraciclicos de lactamas, proceso para su preparacion y composiciones farmaceuticas a base de los mismos.
PL266361A1 (en) Method for manufacturing new tetrahydrobenyotiazole derivatives
ES493888A0 (es) Un metodo de preparar derivados de piperidina
FI890864A0 (fi) Anvaendning av 1,4-dihydropyridinderivat.
SE8500822D0 (sv) Diazepinoindoles, their production and pharmaceutical compositions containing them
DK159847C (da) Salte af 5-cyanopyridin-2-diazohydroxid
ES2043896T3 (es) Procedimiento para la preparacion de derivados de tetrahidropiridina.
DE3676116D1 (de) Herstellung von azetidin-derivaten.
AT375937B (de) Verfahren zur herstellung von 9-hydrazono-6,7,8, 9-tetrahaydro-4h-pyrido (1,2-a) - pyrimidin-4-on- derivaten sowie von deren physiologisch vertraeglichen salzen, hydraten und isomeren
DK74594A (da) Fremgangsmåde til fremstilling af paroxetin eller et farmaceutisk acceptabelt salt deraf
FI905922A0 (fi) Antagonister foer a-adrenerga receptorer.
ATE109454T1 (de) Catecholaminester.
ES532445A0 (es) Procedimiento para preparar 2-alquiltio-1-aminoalquil-2-pirrolin-3-carbonitrilos
SE8501907L (sv) Kristallint d,1-glaucinfosfatsalt